ScoreWhy is Sequent Scientific Ltd ?
1
Weak Long Term Fundamental Strength with a -6.95% CAGR growth in Operating Profits over the last 5 years
- The company has been able to generate a Return on Equity (avg) of 5.10% signifying low profitability per unit of shareholders funds
2
Stock is technically in a Bearish range
- The technical trend has deteriorated from Mildly Bearish on 25-Mar-25 and has generated -1.46% returns since then
- Multiple factors for the stock are Bearish like MACD, Bollinger Band and KST
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Sequent Scien. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Sequent Scien.
8.27%
0.13
53.68%
SENSEX
0.45%
0.03
14.48%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
5.42%
EBIT Growth (5y)
-6.95%
EBIT to Interest (avg)
2.26
Debt to EBITDA (avg)
9.71
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.27
Tax Ratio
24.45%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
18.11%
ROCE (avg)
6.90%
ROE (avg)
5.10%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
188
Industry P/E
33
Price to Book Value
4.87
EV to EBIT
45.94
EV to EBITDA
25.18
EV to Capital Employed
3.40
EV to Sales
2.46
PEG Ratio
1.42
Dividend Yield
NA
ROCE (Latest)
6.42%
ROE (Latest)
2.86%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend18What is working for the Company
PBT LESS OI(Q)
At Rs 2.57 cr has Grown at 144.39%
PAT(HY)
Higher at Rs 9.76 cr
ROCE(HY)
Highest at 7.36%
NET SALES(Q)
Highest at Rs 390.81 cr
-8What is not working for the Company
PAT(Q)
At Rs 3.69 cr has Fallen at -33.1%
INTEREST(9M)
At Rs 45.62 cr has Grown at 21.33%
NON-OPERATING INCOME(Q)
is 69.44 % of Profit Before Tax (PBT
Loading Valuation Snapshot...
Here's what is working for Sequent Scien.
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 2.57 cr has Grown at 144.39%
Year on Year (YoY)MOJO Watch
Near term PBT trend is very positive
PBT less Other Income (Rs Cr)
Net Sales - Quarterly
Highest at Rs 390.81 cr
in the last five quartersMOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Here's what is not working for Sequent Scien.
Profit After Tax (PAT) - Quarterly
At Rs 3.69 cr has Fallen at -33.1%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very negative
PAT (Rs Cr)
Interest - Nine Monthly
At Rs 45.62 cr has Grown at 21.33%
over preceding nine months periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Non Operating Income - Quarterly
is 69.44 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model
Non Operating Income to PBT
Non Operating Income - Quarterly
Highest at Rs 5.84 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
